title: Bilateral choroidal lesions as first sign of recurrence in multiple myeloma - histopathological findings and treatment response to bevacizumab.
authors.affiliation: Department of Ophthalmology, Charite - University Medicine Berlin, Berlin, Germany.
authors.forename: Claudia
authors.initials: C
authors.lastname: Brockmann
authors.affiliation: Institute of Pathology, Charite - University Medicine Berlin, Berlin, Germany.
authors.forename: Barbara
authors.initials: B
authors.lastname: Ingold Heppner
authors.affiliation: Department of Ophthalmology, Charite - University Medicine Berlin, Berlin, Germany.
authors.forename: Antonia M
authors.initials: AM
authors.lastname: Joussen
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000068258:Bevacizumab / Q000008:administration & dosage*; D002829:Choroid / Q000000981:diagnostic imaging*; D020256:Choroidal Neovascularization / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D058449:Intravitreal Injections; D009101:Multiple Myeloma / Q000150:complications* / Q000175:diagnosis; D009364:Neoplasm Recurrence, Local / Q000150:complications* / Q000175:diagnosis; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab